Skip to main content
Top
Published in: Pediatric Nephrology 9/2004

01-09-2004 | Original Article

Anemia in pediatric dialysis patients in End-Stage Renal Disease Network 5

Authors: Jeffrey J. Fadrowski, Susan L. Furth, Barbara A. Fivush

Published in: Pediatric Nephrology | Issue 9/2004

Login to get access

Abstract

To identify demographic and clinical characteristics associated with failure to achieve hemoglobin levels ≥11 g/dl in prevalent pediatric end-stage renal disease (ESRD) patients, a cross-sectional analysis of patient clinical data collected by the Mid-Atlantic Renal Coalition in conjunction with the 2000 and 2001 ESRD Clinical Performance Measures Projects was performed. Ninety-nine patients (mean age 12.6 years, SD 5.4) contributed 119 observations to this analysis. Of patients on hemodialysis, 36.6% were anemic, and 39.5% of patients on peritoneal dialysis (PD) were anemic. Associations between age, race, gender, assigned cause of ESRD, Kt/V, transferrin saturation, time on dialysis, serum albumin, dialysis modality, and the achievement of target hemoglobin were examined. In multivariate logistic regression analyses examining age, dialysis modality, time on dialysis, and serum albumin, each 1-year increase in age was significantly associated with hemoglobin levels <11 g/dl [adjusted odds ratio (OR) 1.18, 95% confidence interval (CI) 1.06–1.32] and PD patients were more than twice as likely to have hemoglobin levels <11 g/dl (adjusted OR 2.62, 95% CI 0.98–7.04). Patients on dialysis for 6 months or more were less likely to be anemic than those on dialysis for less than 6 months (adjusted OR 0.39, 95% CI 0.16–0.99). In conclusion, increasing age, dialysis for less than 6 months, and treatment with PD were predictive of anemia in this population.
Literature
1.
go back to reference ESRD Clinical Performance Measures Project (2001) 2000 Annual Report. Am J Kidney Dis 37[Suppl 3]:S1–S73 ESRD Clinical Performance Measures Project (2001) 2000 Annual Report. Am J Kidney Dis 37[Suppl 3]:S1–S73
2.
go back to reference ESRD Clinical Performance Measures Project (2002) 2001 Annual Report. Am J Kidney Dis 39[Suppl 3]:S4–S98 ESRD Clinical Performance Measures Project (2002) 2001 Annual Report. Am J Kidney Dis 39[Suppl 3]:S4–S98
3.
go back to reference Frankenfield DL, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA (2002) Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17:10–15CrossRefPubMed Frankenfield DL, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA (2002) Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17:10–15CrossRefPubMed
4.
go back to reference Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902CrossRefPubMed Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902CrossRefPubMed
5.
go back to reference Chavers BM, Schnaper HW (2001) Risk factors for cardiovascular disease in children on maintenance dialysis. Adv Ren Replace Ther 8:180–190CrossRefPubMed Chavers BM, Schnaper HW (2001) Risk factors for cardiovascular disease in children on maintenance dialysis. Adv Ren Replace Ther 8:180–190CrossRefPubMed
6.
go back to reference Stefanidis CJ, Koulieri A, Siapera D, Kapogiannis A, Mitsioni A, Michelis K (1992) Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD. Adv Perit Dial 8:460–463PubMed Stefanidis CJ, Koulieri A, Siapera D, Kapogiannis A, Mitsioni A, Michelis K (1992) Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD. Adv Perit Dial 8:460–463PubMed
7.
go back to reference Baraldi E, Montini G, Zanconato S, Zacchello G, Zacchello F (1990) Exercise tolerance after anemia correction with recombinant human erythropoietin in end-stage renal disease. Pediatr Nephrol 4:623–626PubMed Baraldi E, Montini G, Zanconato S, Zacchello G, Zacchello F (1990) Exercise tolerance after anemia correction with recombinant human erythropoietin in end-stage renal disease. Pediatr Nephrol 4:623–626PubMed
8.
go back to reference Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group (1990) The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263:825–830CrossRefPubMed Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group (1990) The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263:825–830CrossRefPubMed
9.
go back to reference IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S182–S238 IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S182–S238
10.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed
11.
go back to reference Steven L, Stigant C, Levin A (2002) Should hemoglobin be normalized in patients with chronic kidney disease? Semin Dial 15:8–13CrossRefPubMed Steven L, Stigant C, Levin A (2002) Should hemoglobin be normalized in patients with chronic kidney disease? Semin Dial 15:8–13CrossRefPubMed
12.
go back to reference Schroder CH, The European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:805–809CrossRefPubMed Schroder CH, The European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:805–809CrossRefPubMed
13.
go back to reference StataCorp (2000) Stata Statistical Software: release 7.0, Stata Corporation, College Station, Texas StataCorp (2000) Stata Statistical Software: release 7.0, Stata Corporation, College Station, Texas
14.
go back to reference I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]: S7–S64 I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]: S7–S64
15.
go back to reference II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S65–S136 II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S65–S136
16.
go back to reference Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K (1993) Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21:138–144PubMed Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K (1993) Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21:138–144PubMed
17.
go back to reference Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS (2003) Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 64:1120–1124CrossRefPubMed Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS (2003) Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 64:1120–1124CrossRefPubMed
18.
go back to reference Matsui DM (1997) Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am 44:1–14PubMed Matsui DM (1997) Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am 44:1–14PubMed
19.
go back to reference Tebbi CK (1993) Treatment compliance in childhood and adolescence. Cancer 71 [Suppl]:3441–3449 Tebbi CK (1993) Treatment compliance in childhood and adolescence. Cancer 71 [Suppl]:3441–3449
20.
go back to reference Chigier E (1992) Compliance in adolescents with epilepsy or diabetes. J Adolesc Health 13:375–379PubMed Chigier E (1992) Compliance in adolescents with epilepsy or diabetes. J Adolesc Health 13:375–379PubMed
21.
go back to reference Meyers KEC, Weiland H, Thomson PD (1992) Paediatric renal transplantation non-compliance. Pediatr Neprol 9:189–192 Meyers KEC, Weiland H, Thomson PD (1992) Paediatric renal transplantation non-compliance. Pediatr Neprol 9:189–192
22.
go back to reference Rocco MV, Bedinger MR, Milam R, Greer JW, McClellan WM, Frankenfield DL (2001) Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level. Am J Kidney Dis 38:813–823PubMed Rocco MV, Bedinger MR, Milam R, Greer JW, McClellan WM, Frankenfield DL (2001) Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level. Am J Kidney Dis 38:813–823PubMed
Metadata
Title
Anemia in pediatric dialysis patients in End-Stage Renal Disease Network 5
Authors
Jeffrey J. Fadrowski
Susan L. Furth
Barbara A. Fivush
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 9/2004
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1544-7

Other articles of this Issue 9/2004

Pediatric Nephrology 9/2004 Go to the issue

Announcement

September 2004

Abstracts

Contents